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Studies of the in vitro humoral immune response have been undertaken in the belief 
that the factors governing initiation and regulation may be more easily manipulated 
in a culture dish than in an intact organism. Previous work, however, demonstrated 
some notable differences  between in vivo and in vitro responses. 
The mouse spleen fragment culture system established by Globerson and Auerbach 
(1), for instance, does not mount a primary antibody response to some soluble hapten- 
protein conjugates that are highly immunogenic in intact mice (this paper), whereas 
the converse is true of a-dinitrophenyl (DNP)l-poly-L-lysine (2) and of several of the 
immunogens used in the present study. It has also been suggested that there is an in- 
verse relation between the in vivo and in vitro response to sheep erythrocytes when 
different strains of mice are compared (3). Another major contrast has been in the class 
composition of the specific  antibody. It has been difficult to detect immunoglobulin 
G (IgG) antibody after primary immunization in cultures,  although some success  has 
been obtained (4, 5). Immunoglobulin M  (IgM) has usually been reported as the sole 
or predominant component. 
We have examined the antibody response of mouse spleen fragments stimu- 
lated in vitro by a  series of conjugates of the haptenic determinant  3-nitro-5- 
iodo-4-hydroxyphenylacetic acid (NIP)  (6). The culture system has been used 
extensively  (1,  2,  7),  yet  no  detailed  study  has  been  presented  of  the  class 
distribution  of the secreted  antibodies  or of the  types of antigens  effective in 
eliciting a primary response. 
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Materials and Methods 
Animals.--Female C57BL/6 mice, 2-3 mo old, were used for the experiments in this study. 
Antigens.--Poly-x-lysine (PLL)  hydrogen bromide of tool wt  in the range 30,000-50,000 
was purchased from Miles Laboratories, Rehovot, Israel, polysaccharide SIII from Burroughs- 
Wellcome Laboratories, Beckenham, England, and keyhole linapet hemocyanin (KLH)  was 
prepared from material obtained from Pacific Bio-Marine Supply Co., Venice, Calif.  Chicken 
globulin (CG) was prepared in this laboratory (T. Imanishi) by salt fractionation  (50%  sat- 
urated solution of (NH4)2SO~) from serum. 
NIP-CG was prepared by adding 4% NIP-azide (6) in dimethyl forrnamide to 10-20 mg/ml 
solutions of protein in 3% sodium bicarbonate. The quantities of hapten added were adjusted 
until a final conjugation ratio was obtained of 15 mol of NIP per tool of CG. NIP-poly-L-lysine 
with a substitution of 0.6% of the lysine residues was obtained by the same approach. NIP- 
KLH was prepared by adding 30 #1 of 4% NIP-azide in dimethyt formamide to 6 ml of 1% 
sodium bicarbonate containing 30 mg of KLH.  All reactions were allowed to go overnight at 
4°C.  Excess free hapten was removed by dialysis against phosphate-buffered saline solution 
(PBS).  Antigen solutions were  sterilized by  Millipore filtration  (Millipore Corp.,  Bedford, 
Mass.)  and stored at  +4°C. 
The preparation  of NIP-ethylenediamine-SIII  (NIP-SIII)  was  based on the  method  of 
Mitchell et al. (8) for DNP-lysine-SIII. 50 mg of SIII was dissolved in 3 ml of water, pH 9.0, 
and the pH was adjusted to 10 with 0.01  M  NaOH.  Freshly dissolved cyanogen bromide (25 
mg in 1.0 ml of H20) was added to the polysaccharide solution, and the "activation" reaction 
(9) allowed to proceed, with stirring, pH maintained at 10.0-10.5, by addition of 0.1 M NaOH 
for 7 rain. After addition of 0.5 ml of 1 M  NaHCO~,  NIP-ethylenediamine (10)  (33.5 mg in 
1.5 ml, pH 8) was added and stirring continued at room temperature for 4 h; then overnight 
at 4°C. The reaction solution was dialyzed against water previously adjusted to pH 8.0 with 
NaHCO~.  Unbound hapten was further removed by precipitation with potassium acetate- 
saturated ethanol, and the precipitate was  redissolved in  water. This step was repeated six 
times, followed by successive dialyses against 0.05 ethanolamine, 8 M urea-0.1 M borate buffer 
(pH 8.3), 0.1 M citrate buffer (pH 2.6), 0.1 M carbonate buffer (pH 10.0), and finally against 
water. The final product contained 0.1 tool of NIP per tool of the aldobiuronic units making 
up the polysaccharide. This was diluted for use in appropriate dilutions in sterile PBS. 
NIP-sheep erythrocytes (NIP-SRBC's) were prepared according to Pasanen and M~ikel/i 
(11)  in  a  0.12  M  carbonate-bicarbonate buffer, pH  9.25,  containing  1 vol of  20% washed 
erythrocytes and 1 vol of 0.4% NIP-azide introduced into the buffer from a 4% solution in 
dimethyl formamide. The mixture was kept at room temperature for 1 h, then washed and 
suspended as a  1% vol/vol suspension in sterile PBS. 
Culture Technlque.--The Millipore filter well technique for organ culture of mouse spleen 
fragments was used as previously described for the induction of primary responses to sheep 
erythrocytes (1)  and to the 2,4-dinitrophenyl (DNP)  determinant  (2),  except that Eagle's 
minimal essential medium was used instead of Dulbecco's modified Eagle's medium and that 
the chick embryo extract was omitted. The spleen fragments, of 1.0  X  1.0 X  2.0 mm dimen- 
sions, were prepared with a Mcllwaine tissue chopper machine (Mickle Laboratory Engineer- 
ing Co., Guilford, England). The culture medium was changed every 2 days. Thus, the anti- 
body titer of "6 day medium" designates the antibody content of medium serving for culture 
between days 4 and 6. Antigen was added in a volume of 0.01 ml of PBS, placed directly on 
each fragment from a syringe with a 25 gauge needle. NIP-PLL and NIP-SIII were used at 
doses of 20 and 0.2/zg per spleen fragment, respectively, unless otherwise indicated. All anti- 
gens were added to the spleen cultures within 1 h of explantation. 
Anti-NIP Antibody Assay.--The  preparation  of  NIP-conjugated  bacteriophage T2  and 
the measurement of haptenated phage inactivation have been described previously (12). The 
haptenated phage inactivation titers reported in this paper are the reciprocals of the antibody ICHIRO  NAKAMURA~ ALEX  RAY~ AND  O.  ~LA  975 
dilutions in the final incubation mixture of antibody and phage necessary to inhibit 50% of 
the plaque-forming units. 
Antimouse Immunoglobulin A  (IgA)  Antiserum.--Rabbits  were immunized with a-chain 
purified from MOPC 315 ascites fluid  (kindly provided by Dr. H. Wigzell) by a modifcation 
of the methods described by Goetzl and Metzger (13). The ascites fluid was dialyzed into pH 
8.6 0.2 M Tris-HC1 buffer and reduced under mild conditions  with 0.01 M  dithiothreitol  for 1 h 
at  room temperature. The pH was then adjusted to 8.0, and iodoacetamide added to a con- 
centration of 0.011  M. Mter a  further 15  min at room temperature the fluid was dialyzed 
against pH 8.0 borate-NaC1 buffer and applied to a DNP-lysine-Sepharose  immunoadsorbent 
column (14). The DNP-binding myeloma protein was eluted from the column with a 2.5 mM 
DNP-lysine solution and dialyzed successively against PBS and water to remove free hapten. 
Finally, the protein solution was concentrated by in vacuo dialysis against 1 M propionic acid, 
and passed through a  column of Sephadex G-100  equilibrated with the same solvent. The 
three peaks of eluted polypeptide chains, monitored by their light absorption at a wavelength 
of 280 nm, were pooled, concentrated, and then dialyzed against several changes of PBS. 
Two rabbits were each immunized with 1.1 mg of protein from the second, heavy chain 
(15) pool. An identical booster was given 1 mo later, and a final booster consisting of material 
from the first, or "aggregate" pool, was administered after an additional month. The rabbits 
were bled at brief intervals thereafter and finally exsanguinated. The antiserum was rendered 
monospecific for IgA by passage through a mouse IgG-Sepharose  4B immunoadsorbent  column. 
The  absorbed antimouse IgA serum used in  these experiments was immunoelectropho- 
retically monospecific  for IgA against both normal mouse serum and the MOPC 315 ascites 
fluid. On sucrose density gradient centrifugation it exerted no suppressive effect on anti-NIP 
activity in the fast  (IgM)  and slow  (IgG)  velocity peaks from immune culture media or 
mouse serum even at the lowest dilution tested, 1:10.  It did, however, eliminate entirely the 
IgA anti-NIP antibody of intermediate sedimentation velocity at a dilution of 1:100. 
Sucrose density gradient centrifugations shown in the Results section of this article demon- 
strate the monospecificity of the antiserum with respect to the antibody classes that inhibit 
the plaque-forming ability of haptenated bacteriophage. In addition, data from this laboratory 
(M. Kaartinen, unpublished observations) indicate that the antiserum is similarly monospecific 
in eliminating an anti-NIP antibody peak from rat lymph that sediments between IgM and 
IgG. Mouse IgA has been shown to cross-react with rat IgA (16). 
Rabbit Antimouse IgG Antiserum.--Prepared previously in this laboratory, it was shown to 
be monospecific for IgG by the same criteria applied to the anti-IgA serum. It derives from 
rabbits. Sheep antirabbit Ig serum was a gift from Dr. E. Ruoslahti. 
Sucrose Gradient Centrifugation.--This method was used for physical separation of IgM, 
IgA, and IgG components of the anti-NIP antibody secreted into culture media.  Medium 
(0.1 ml) was layered on top of a  10-35% continuous sucrose gradient in PBS  (vol 5.4 ml). 
Gradient tubes were centrifuged at 40,000 rpm for 16.5 h in a Beckmann L3-50 ultracentrifuge 
using an SW50L  swinging bucket rotor (Beckman Instruments, Inc., Spinco Div., Palo Alto, 
Calif.). 10 fractions were collected from each gradient through a  hole made in the bottom of 
the tube with a needle. The fractions were titered for antibody activity on the same day. 
Hemolytic Plaque Assay.--NIP sheep erythrocytes for the plaque assay were prepared by 
the same procedure as the immunogenic erythrocytes except that the final concentration of 
NIP-azide was 0.6%. They were prepared immediately before each assay. The extent of cou- 
pling was routinely tested by measuring the hemagglutination titer of a  standard anti-NIP 
serum with each batch of NIP-SRBC. Suspensions of lymphoid cells were prepared from cul- 
tured spleen fragments as described by Nakamura et al.  (17). The plaquing technique was a 
modification of that developed by Cunningham and Szenberg (18).  Briefly,  0.3  ml of 10% 
NIP-SRBC suspension and 0.1 ml of undiluted guinea pig complement were added to 0.6 ml of 
Eagle's minimal essential medium. A 0.4 ml aliquot of this mixture was then mixed with 0.2 976  IN  VITRO IGA PRODUCTION BY  MOUSE SPLEEN FRAGMENTS 
ml of the appropriate splenocyte suspension, and a]iquots of this mixture were pipetted with 
a Pasteur pipette into slide chambers calibrated to have a capacity of 0.1 ml. The chambers 
were sealed with Vaseline and incubated for 30 min at 37°C. Plaques were then counted under 
binocular microscope. IgA indirect  plaques were developed by substituting 0.6 ml of the 
appropriate  dilution of rabbit antimouse IgA serum for the 0.6 ml of medium in the NIP- 
SRBC plus complement mixture. A final anti-IgA dilution of 1:400 gave maximal enhancement 
of the number of plaque-forming cells (PFC). Some inhibition of direct plaques was detected, 
and the percentage of inhibition at this dilution interpolated from 4-day cultures responding 
to NIP-PLL, which do not have indirect plaque-forming cells of the IgA class. Each reaction 
mixture was assayed in triplicate. 
Inhibition of Antibody Activity.--NIP-caproic acid and NIP14-bovine  serum albumin  (NIP14 
BSA) were used as inhibitors. The procedures and ca]culations are described by Sarvas and 
M~kel~ (12) for  inhibition of haptenated  phage inactivation  and by Imanishi and M~kel~ 
(19) for inhibition of plaque formation. 
RESULTS 
Immunogenicity of NIP-Conjugates as In  Vitro  Primary Antigens.--Spleen 
fragments were stimulated in vitro with NIP coupled to various carriers: the 
synthetic  polypeptide  PLL,  the  thymus-independent  (20)  polysaccharide 
antigen SIII,  sheep  erythrocytes,  the polymeric protein  KLH,  and  chicken 
globulin. All these conjugates except NIP-CG elicited the production of anti- 
NIP antibody in vitro. The dose response curves for NIP-PLL and NIP-SIII 
are shown in Fig. 1. Only the day 4 and day 8 titers are given. The kinetics of 
the in vitro response is nearly identical for all of the immunogenic conjugates 
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FIO. 1.  Antigen dose dependence of the anti-NIP response. 0--0:  antigen e-NIP-PLL, 
day 4 titer; Q--O: antigen the same, day 8 titer; A---A: antigen NIP-SIII, day 4 titer; 
A---A: antigen the same, day 8 titer. Vertical bars indicate standard error. ICIIIR0 NAKAM~IRA,  ALEX RAY, AND  O. M_&KELA  977 
(Fig. 2). Peak titers are found in media collected at days 8 and 10. The data for 
unstimulated control cultures were pooled and for convenience presented only 
in  Fig.  2 A. In these  two experiments each spleen was evaluated separately, 
and the results obtained from 4  to 10 spleens, mostly by independent  experi- 
ments, were combined as average titers. The standard errors thus indicate the 
degree of variation between spleens and at the same time show the degree of 
reproducibility of independent experiments. 
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FIG. 2. A-D. Kinetics of primary anti-NIP antibody response in vitro. Open circles show 
average anti-NIP titer in culture media after stimulation with: A, e-NIP-PLL  (20 #g); B, 
NIP-KLH (2 #g) ; C, NIP-SRBC (2 X 106)  ; D, NIP-SIII (0.2/zg). Closed circles show back- 
ground anti-NIP titer in unstimulated control cultures. Vertical bars indicate standard error. 
The conjugate of SIII elicited the strongest peak (8 day) response as shown in 
Table I.  PLL and  SRBC  were  also effective carriers,  whereas  a  response to 
NIP-CG could only be demonstrated in one spleen. The poor in vitro immuno- 
genicity of NIP-CG was confirmed by testing a  1,000-fold range of doses. The 
immunogenicities of NIP-SIII, NIP-PLL, NIP-SRBC,  and  NIP-CG in  vivo 
were tested for comparison. The "hierarchy" of responses at optimal antigen 
doses is quite different, most strikingly in the relative positions of the PLL and 
CG conjugates.  The strong in vitro antigen  NIP-PLL is quite  weak in vivo, 
whereas the reverse is true of NIP-CG. 
Immunoglobulin  Classes of  Anti-NIP  Antibody  Produced in  the  In  Vitro 
Primary Response.--At no time during the 12 days of in vitro primary response 
studied was a significant amount of 2-mercaptoethanol-resistant antibody pro- 978  IN  VITRO  IGA  PRODUCTION  BY  MOUSE  SPLEEN  FRAGMENTS 
duced  (Table  I).  The  antibodies  were  analyzed  further  by  centrifugation 
through a sucrose gradient. Fig. 3 shows the gradient profiles of media collected 
on day 4 and day 8 from the same series of fragment cultures stimulated with 
NIP-PLL. A rabbit anti-DNP serum was added to the samples before centrifu- 
gation as markers for the IgM and IgG positions. The day 4 medium exhibited 
only a fast-moving component that corresponded in position exactly to that of 
the marker IgM, whereas the position of antibody from day 8 medium was 
intermediate between IgM and IgG.  Anti-NIP  antibodies induced by NIP- 
KLH, NIP-SRBC, and NIP-SIII had similar sedimentation patterns: the fast- 
moving component in day 4 media and the predominance of the slower-moving 
peak in day 8 media. 
TABLE I 
Antibody Respometo NIP Co~ugatesln  ~troa~  In  Vivo 
In vitro titer*  In vivo titer 
Dose per  Dose~ per  7th day  14th day 
2-ME-  mouse 
Antigen  culture  Total  resistant  Total  resistant2-ME-  Total  2-ME- 
resistant 
NIP-SIII  0.2#g  27,300  4.2  10/zg  273,000  5,100  129,000  5,400 
NIP-PLL  20/zg  6,000  <3  10#g  3,900  <90  6,900  477 
100 Izg  4,800  <90  51,000  3,600 
NIP-SRBC  2 X  105  4,430  6.0  108  660,000  48,000  1,470,000  174,000 
NIP-KLH  20/zg  1,990  5.7  n.d. 
N IP-CG  20/zg  374§  <3  10/zg  141,000  19,200  9,000,000  2,424,000 
None  <3  1,440  <90 
Titers of the table were obtained with approximately optimal antigen doses. In vitro titers are log means of 
4-10 spleens, in vivo titers are log means of six mice. 
* In vitro titers are from day 8 (peak titers). 
++ Subcutaneous  injections  in  complete Freund's adjuvant, except NIP-SRBC, which was injected intraperi- 
toneally in saline  solution. 
§ NIP-CG is not usually immunogenic for unprimed spleen  fragments. These titers are from one mouse,  which 
was an exception,  and received  20/~g. 
Serum  IgA's  of  most  species  have  sedimentation  velocities  intermediate 
between those of IgM and IgG (21).  We established the identity of the slow- 
moving antibody characteristic of primary response culture  media by using 
antiserum specific for mouse IgA in conjunction with sucrose gradient centrifu- 
gation. Routinely, 2 #1 of antiserum was added to 200 #1 of culture medium in a 
small glass tube. This tube and a control tube containing only culture media 
were sealed with parafilm, incubated 1 h  at an air temperature of 37°C,  and 
then kept at 4°C overnight.  100 #1 from each solution was layered on separate 
sucrose  gradients  and  centrifuged.  Gradient profiles show  the  separation  of 
anti-NIP  activity into components of different sedimentation velocities. The 
anti-IgA serum caused the disappearance of the peak at intermediate velocity 
(tube 4). This could be due to actual precipitation of IgA by anti-IgA, or to the 
formation of soluble,  inactive complexes  that  end up  at  the  bottom of the 
gradient in conditions of antibody excess. Suppression of IgG antibody activity ICHIR0  NAKAMURA,  ALEX  RAY~ AND  0.  M~KELA  979 
by this procedure led to the appearance of some active IgG-anti-IgG complexes 
in the "fast" region of the gradient pattern. Accordingly, a sheep antirabbit Ig 
serum  was  added  to  medium-anti-mouse  IgG  mixtures  after  the  overnight 
incubation and incubated an additional hour at 37°C and 4 h  at 4°C to assist 
complex formation. 
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FIG.  3.  Sedimentation patterns of anti-NIP  antibody.  Open  circles  show  anti-DNP  ac- 
tivity of a  serum mixed into culture medium as a  marker  before the centrifugation. Closed 
circles show anti-NIP activity of the culture medium harvested at day 4  (a)  or day 8  (b)  of 
the same culture. 
A  day 8  anti-NIP-SIII medium  (diluted fourfold) was  treated with  either 
rabbit anti-IgA or anti-IgG serum. A hyperimmune mouse anti-NIP serum had 
been added to the medium before treatment as a marker for the IgG position 
in  the  gradient profile. The anti-IgA  serum completely suppressed  the  anti- 980  IN VITRO IGA PRODUCTION BY  ]~OUSE SPLEEN FRAGMENTS 
NIP activity derived from the culture medium (Fig. 4, fraction 4), leaving the 
IgG marker intact,  while anti-IgG serum abolished the marker IgG peak and 
left  the  activity  from  the  medium  unaffected.  Using  the  above  method  of 
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FIG. 4.  Effects of preincubation with anti-c~ or anti-'y serum. O--O: Control  mixture of 
day 8 culture  medium and hyperimmune anti-NIP serum.  Q--O : The same preincubated 
with anti-'), serum. A--A: The same preincubated with anti-a. Fourfold  diluted anti-NIP- 
SIII medium was used. 
immunoglobulin  class  identification  we  examined  in  detail  the  response  to 
NIP-PLL and NIP-SIII. Both IgM and IgA antibodies were detected in vitro, 
but no IgG. In terms of the  time-course of the response,  IgM appeared first, 
and was gradually superceded by IgA. By day 8, most of the antibody activity 
belonged to the IgA class. The lowest ratio of IgA/IgM sucrose gradient peaks ICHIRO  NAKAMLrRA,  ALEX  RAY,  AND  O.  MAKELA.  981 
was 6.5 at that time. Many day 8 media lacked detectable IgM activity alto- 
gether. 
Immunoglobulin  Classes  of Antibody Secreted  by Hemolytic  Plaque-Forming 
Cells during the Primary In Vitro Response.--As would be expected, anti-NIP 
hemolytic plaque-forming cells (PFC's) were detected in splenocyte suspensions 
made from the cultured fragments (Table II). Only direct (IgM) PFC's were 
present  at day 4  of the primary response against  both NIP-PLL and NIP- 
SIII. By day 8, almost all of the PFC's in the anti-NIP-PLL response were at 
the  IgA class, requiring "facilitation" by anti-IgA serum. NIP-SIII induced 
a  longer-lasting IgM  PFC response. In some experiments direct plaques still 
were a major component at the 8th day, but usually IgA PFC's had replaced 
TABLE II 
IgM and IgA  Hemolytic Plaque-Forming Cells from Spleen Explants Immunized In  Vitro 
Antigen  Time of 
culture 
Anti-NIP PFC/10  6 recovered cells* 
IgM  IgA 
day 
NIP-PLL (20 t~g)  4  2,150  0 
....  8  150  1,770 
....  8  50  1,690 
NIP-SIII (0.2 #g)  4  4,750  0 
"  "  8  27,300  33,200 
....  8  1,770  8,438 
NIP-SIII (0.02 ~g)  8  1,698  19,622 
....  8  2,800  10,000 
....  8  2,875  20,125 
* Each value represents a pool of two spleens  from a single experiment. 
them by that  time.  In general, IgM  elicited by both the NIP-PLL and the 
NIP-SIII antigens was seen as a larger component of the PFC response than of 
the antibody secreted into the media. The direct PFC's at days 4 and 8 may 
therefore not be secreting antibody as rapidly as the IgA PFC's. 
Polymeric Nature of IgA Anti-NIP Antibody Secreted by Spleen Fragments.- 
The sucrose gradient centrifugation patterns of Figs. 1 and 2 indicated that the 
IgA molecules secreted by mouse spleen fragments are of a larger size than IgG 
and are therefore probably polymeric. To establish this in terms of multivalency 
for binding sites, IgM, IgA, and IgG anti-NIP antibodies from culture media 
were compared by the method of inhibition of haptenated phage inactivation 
(12). The superiority of multivalent inhibitors over free hapten is expected to 
be more impressive the higher the valency of the antibody being tested (12). 
Table III summarizes the results with NIP+aminocaproic acid and with NIPx4 
BSA as inhibitors. The pattern of avidity for polyvalent and for monovalent 982  IN  VITRO  IGA  PRODUCTION  BY  MOUSE  SPLEEN  FRAGMENTS 
molecules indicates  that  the  valency of the  anti-NIP  IgA was intermediate 
between those of IgM and IgG, and resembled more strongly the former. Table 
IV shows  the  analogous pattern  for inhibition  of IgM  (direct)  and IgA  (in- 
direct) PFC's from 8-day cultures. 
TABLE III 
Inhibition  of Haptenated Phage Inactivation by Culture Media from Spleen Explants 
Immunized  In Vitro* 
Main immuno-  Antigen  Time of culture  globulin class 
HPII* 
NIP-cap  NIP14BSA 
day 
NIP-PLL  4  IgM  25,333  0.41 
NIP-PLL  8  IgA  6,583  0.40 
NIP-CG  8 (in vivo)  IgG  534  0.70 
* Means of three to five sera or cultures. 
J~ Nanomolar concentration of NIP-hapten that reduced the NIP-phage inactivation titer 
by 50~o; each figure is the mean of at least three culture media or sera. 
TABLE IV 
Inhibition  of Hemolytic  Plaque-Forming  Cells from  Spleen  Explants  bnmunized  In  Vitro 
PFC inhibition* 
Immunogiobulin  class 
NIP-cap  NIP14BSA 
IgM  i0  0.1 
IgA  30  3.0 
* Micromolar concentration of NIP-hapten that reduced the number of anti-NIP PFC by 
50%. 
The  sedimentation  velocity of IgA in  a  fresh,  unfrozen  aliquot  at  day  8 
medium from an NIP-PLL-stimulated culture was identical with that from a 
repeazedly frozen and thawed aliquot of the same medium as shown in Fig. 5. 
Thus,  the sedimentation of the  antibody relative  to IgM and IgG is not  an 
artifact of our procedure of storing most media at -- 20°C  before analysis. The 
same figure  allows  comparison with  the  sedimentation  velocity of IgA anti- 
NIP from colostrum of immunized rabbits  (22).  The  mouse spleen  IgA was 
slightly faster than the dimeric (23)  rabbit immunoglobulin. 
DISCUSSION 
The central findings of this report is that oligomeric antibodies of the IgA 
class  are  the  predominant  component  of  the  primary response  mounted  by ICHIRO  NAKAMIrRA~  ALEX  RA¥~ AND  O. M_AKELA  983 
spleen explants against hapten carrier conjugates. This conclusion is based upon 
the  sedimentation  velocity of  the  secreted  antibody,  which  is  intermediate 
between the velocities of IgM and IgG, upon the removal of this predominant 
component  from  the  sedimentation  profile  by  preincubation  with  a  mono- 
specific anti-IgA antiserum, and upon the high number of IgA plaque-forming 
cells found in the cultures. IgA is only a minor proportion of the mouse serum 
immunoglobulins (24, 25) and is not usually detected in the immune response 
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of intact mice. Th  e primary antihapten response by cultured spleen fragments 
also differed from the response of intact mice with respect to the immunogenicity 
of the various antigens. In vivo, NIP-CG was very immunogenic and NIP-PLL 
was  a  very weak antigen.  In  culture the  reverse was  true.  Another hapten- 
protein conjugate commonly immunogenic in vivo, NIP-ovalbumin (OA), also 
failed to elicit a primary in vitro response (I. Nakamura, unpublished results). 
The prevalence of oligomeric IgA in culture was not restricted to those anti- 
gens capable of eliciting a primary response. Protein conjugates NIP-OA and 
NIP-CG could be immunogenic to spleen fragments, but only if these came from 
mice preimmunized with the carrier (Nakamura et al., unpublished observa- 984  IN  VITRO  IGA  PRODUCTION  BY  MOUSE  SPLEEN  FRAGMENTS 
tions).  This response,  which  was  probably T  cell dependent, was  again pre- 
dominantly  IgA.  Therefore the  culture  system,  rather  than  any  particular 
antigen or helper cell population, seems to be responsible for the preferred IgA 
production. 
The single other observation of IgA antibody production by spleen cells im- 
munized in vitro enumerated a peak response of 45 PFC/106 cells, whereas the 
IgM  and  IgG  peak  responses  were  approximately 2,000  and  700  PFC/10  ~, 
respectively (4). Quantitative c~mparison of the two studies is difficult, how- 
ever, because the culture conditions were different. Pierce et al. described the 
response of cell  suspension cultures at 5  days after immunization,  a  time at 
which  we  also  found mainly IgM  antibody.  Nothing  was  known  about  the 
molecular size of the IgA observed in this study. Available data do not there- 
fore argue  against  oligomeric IgA  being an important  component in  splenic 
primary responses taking place in culture for more than 4 days. 
Our  findings  are  supported  by observations  that  some  23-28%  of mouse 
splenocytes bear surface IgA demonstrable by autoradiography (26,  27).  The 
low level of IgA in mouse serum,  approximately one-tenth that of IgG, may 
reflect its rate of catabolism rather than a lack of cells committed to IgA syn- 
thesis. The half-life of mouse serum IgA is about 0.5 days, whereas the half-life 
of IgG is more than 4 days (28). The same consideration applies to the failure 
of  many investigators,  including  ourselves,  to  detect  oligomeric serum  IgA 
antibodies in immune responses of intact mice. Kearney and Halliday, however, 
did detect serum IgA antibody against SIII (29) and hemagglutinating antibody 
(probably IgA) of a molecular size larger than ca. 200,000 (30). The detection 
of IgA plaque-forming cells in  spleens of immunized mice has  only been re- 
ported  with  sheep  erythrocytes or Escherichia  coli lipopolysaccharide as  the 
antigen (31-35).  This may be due to a lack of attempts to detect IgA PFC in 
vivo, or may actually reflect a relative enrichment of antibody-producing cells 
in the in vitro systems, where the viability of nonproducers is thought to be low. 
An alternative explanation that has not been excluded hypothesizes feedback 
regulation of IgA production by IgG antibody. The predominance of IgA in 
the fragment culture response would  thus  be a  result of the absence of IgG, 
and the serum IgG of intact mice would suppress IgA PFC and serum levels. 
The relative in vitro antigenicities of our NIP-conjugates may be a reflection 
of their respective abilities to stimulate T  cell-independent responses. SIII was 
shown by Howard et al.  (20)  to be completely independent of T-B cell inter- 
action in vivo. Conceivably, electrostatic binding between cationic PLL and 
anionic lymphocyte surfaces might obviate the requirement for T  cells in the 
case of NIP-PLL in vitro, and binding with serum proteins might decrease the 
likelihood  that  this  conjugate would  even arrive at  the  lymphoid organs  of 
intact mice. Another possibility that must be considered as explanation for the 
strong antigenicity in culture of NIP-SIII, NIP-SRBC, and NIP-PLL is that 
these conjugates may be mitogenic, whereas CG and ovalbumin are not. Mito- ICHIRO  NAKAMURA, ALEX RAY, AND  O.  MAKELA  985 
gens are known to induce antibody formation in vitro (36), and mitogenicity of 
a carrier moiety might therefore potentiate a response to the hapten. The fact 
that SIII has been demonstrated to be a mitogen (37) may support this explana- 
tion. 
A point that may complicate evaluation of the immunogenicity data is our 
preliminary findings on the marked strain difference in mice in the capacity to 
mount a primary response in vitro (I. Nakamura and A. Ray, unpublished). 
For instance, C57BL/6 and BALB/c but not C3H and CBA strains respondecl 
strongly when challenged with the same antigen in the same culture conditions. 
IgA is also the main component of the BALB/c response. Investigations of both 
T  cell participation and strain  differences in  the primary response of spleen 
fragments are now under way. 
Antibody responses rich in IgA are generally associated with local immuniza- 
tion of mucosal surfaces (38).  There is evidence in mouse (39) and dogs (40), 
both of whose serum IgA is predominantly polymeric, that the intestinal lym- 
phoid  tissue helps  to maintain the  serum IgA levels.  Oral  immunization of 
germfree mice with sheep erythrocytes or ferritin (34, 41) led to the appearance 
of IgA antibody-producing cells in extraintestinal lymphoid organs according 
to a  time sequence consistent with migration of antigen-stimulated cells from 
the gut. These data have led to two suggestions: (a)  that dimeric serum IgA 
originates from the mucosae, and that the proportion of monomer in the serum 
may be an index of extramucosal contribution  (38),  and  (b)  that the  extra- 
intestinal IgA-secreting cells  found after parental  immunization might have 
met with the antigen in the gut mucosae and hence migrated to the peripheral 
organs (42).  Our data suggest that polymeric serum IgA can be produced by 
precursors residing in the spleen before the antigen was introduced and together 
with the data of Pierce et al.  (4)  they prove that precursors of IgA-secreting 
cells reside in the normal mouse spleen. This is in agreement with the finding 
of Craig and Cebra (43)  that IgA precursors in Peyer's patches, the enriched 
source, not only repopulated the gut when transferred into lethally radiated 
recipients but also localized in the spleen.  The autoradiographic data of Bank- 
hurst and Warner (26) and Nossal et al. (27) discussed above are also in agree- 
ment with this view. 
SUMMARY 
The primary antibody response elicited from mouse spleen explants by conju- 
gates of the 3-nitro-5-iodo-4-hydroxyphenylacetic acid (NIP) hapten consisted 
mostly of the IgA class. Poly-L-lysine, pneumococcal polysaccharide Type SIII, 
keyhole limpet hemocyanin, and sheep erythrocytes were effective carriers in 
this system, whereas chicken globulin was not. The anti-NIP response against 
all of the immunogenic conjugates was detectable in culture media 4 days after 
explantation and immunization, and reached peak titers by 8-10 days. IgA was 
identified by sucrose gradient velocity centrifugation in conjunction with the 986  IN  VITRO  IGA  PRODUCTION  BY  MOUSE  SPLEEN  FRAGMENTS 
use of a  class-specific antiserum.  The media collected at 4  days contained low 
titers  of IgM antibody, whereas the peak response at 8 days consisted almost 
entirely of IgA. 
The primary response IgA secreted by the spleen fragments was characterized 
as  polymeric  by  its  sedimentation  rate  through  a  sucrose  gradient,  and  as 
polyvalent by its drastically greater avidity for NIP14BSA than for free NIP- 
aminocaproic  acid.  Its  haptenated  phage-inactivating  activity  was  abolished 
by treatment with 0.1 M  2-mercaptoethanol. 
These experiments indicate that precursor cells existing in the spleen before 
primary immunization can give rise to production of polymeric IgA. 
The authors are grateful to Eila Pelkonen and Kaija Rytsy for excellent technical assitance 
and to Thereza Imanishi for great help in the enumeration of plaque-forming cells. 
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